파로스백신

GMP Facility

Cellular and Gene Therapeutics GMP Facility

Pharos Vaccine is establishing Good Manufacturing Practice (GMP) manufacturing facilities for advanced bio-pharmaceuticals to achieve approval from the Ministry of Food and Drug Safety (MFDS) for an Advanced Regenerative Medicine Cell Processing Facility in 2020.
We are planning to perform manufacturing of investigational products, quality control, and other consignment tests utilizing our development technologies for cell and gene therapies and our excellent personnel.